Where Tech Meets Bio
Latest News
BioAge Labs reported second-quarter 2025 results alongside updates on its metabolic disease pipeline and human aging data platform. The company is advancing its oral NLRP3 …
Read More
Strand Therapeutics Secures $153 Million for Programmable mRNA Cancer Therapies
Strand Therapeutics has closed a $153 million Series B financing led by Swedish investment firm Kinnevik, joined by Regeneron Ventures, ICONIQ, Amgen Ventures, Alderline Group, …
Read More
XtalPi And DoveTree Finalize $6B AI Drug Discovery Agreement
XtalPi has signed a definitive agreement with DoveTree Medicines for an AI- and robotics-powered drug discovery collaboration valued at up to $5.99 billion. The deal …
Read More
Latest News
Chai Discovery Raises $70M to Expand Zero-Shot Biologics Design AI Platform
WVU Cancer Institute Adopts Ryght AI Tools for Trial Matching and Enrollment
NIH Foundation Launches Industry-Backed Program to Advance Non-Animal Testing Methods Toward Regulatory Use
Recursion Reports Q2 2025 with $7M Sanofi Milestone, Announces Clinical Updates
Lantern Pharma Launches AI Platform for Blood-Brain Barrier Permeability Prediction, Completes Japan Trial Enrollment
Ultromics Gets $55M to Spot Hidden Heart Failure with AI Ultrasound
Latest Insights
by Dominik Tomicevic
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is projected to rise to 13.8 …
Read More
by Louise von Stechow
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding DNA—the so-called “dark genome” has …
Read More
"AI Scientists" - New Collaborators for Rare Disease Research?
by Louise von Stechow
What are Foundation Models in Biology and Healthcare?
by BiopharmaTrend
The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms
by BiopharmaTrend
Building AI Solutions for Life Sciences and Healthcare
by BiopharmaTrend
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
by Louise von Stechow
Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond
by Andrii Buvailo, PhD, Oleg Kucheriavyi, PhD
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
From Our Partners
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
Lantern Pharma
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Partner Events

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Drug Discovery Innovation Programme
Event Date: Sept. 25, 2025 - Sept. 26, 2025
Location: Spain (InterContinental Barcelona, Spain)
Website: Link
Promo Code: YOUSAVE15 (valid till 2025-08-15)
Read more ›››

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››
Case Studies
Sponsored by
BenchSci
From Data to Discovery: How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Interviews
Merging AI and Quantum Computing To Boost Drug Discovery
This South Korean Company is at the Forefront of AI-driven Drug Discovery
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Most Read
--
17 Companies Building the Future of Drug Development on a Chip
--
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
--
21 Life Science Marketplaces to Try in 2024
--
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals